Skip to main content

noComment
Merck to merge with Schering-Plough

corporate

| |

US drug maker Merck is to buy Schering-Plough in the second huge takeover in the sector in weeks following Pfizer’s recent purchase of Wyeth.

Merck will pay 41 billion dollars (32.5 billion euros); that represents a premium of just over a third from last Friday’s closing price for Schering-Plough shares. Combined Merck and Schering-Plough will be the world’s fourth largest drugmaker in terms of revenues with 33.5 billion euros last year. In top position is the merged Pfizer and Wyeth. Pharmaceutical firms worldwide are looking to become more efficient with cost savings as well as for ways to take capacity out of an over-supplied industry That is because they are faced with the problems of slowing sales, patents expiring so that other companies can make cheaper versions of their drugs and sliding prices. In addition, the industry is being pressured by politicians through moves to cut government health service costs.More about:

Copyright © 2012 euronews

| |

Top Stories

Greek gathering fails to agree on bailout deal terms

Greek gathering fails to agree on bailout deal terms

Greece’s coalition party leaders have failed to agree on a tough reform and austerity package to secure a fresh bailout of 130-billion euros After seven hours of talks overnight, they came close to securing a deal to avoid a painful default…

Syrian military intensify shelling of Homs

Syrian military intensify shelling of Homs The plight of people in the Syrian city of Homs became all the more grave after yesterday…

Europe's big freeze to continue until end of February

Europe's big freeze to continue until end of February The freezing weather gripping much of Europe could last until the end of the month according to…

Login

Please enter your login details

Join the euronews community

By joining euronews’ community , you can participate to U talk and I talk and subscribe to our newsletters.
Please note: All fields are required